Regulation of ERAD pathway

Across TCGA patient cohorts, RNA activity of the Regulation of ERAD pathway pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are RARB, CHRM3-AS1, and MEFV, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Regulation of ERAD pathway activity versus RARB in LUAD (Pearson r = -0.34).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUAD	RARB →	-0.421	-0.146	.002	.002	2	5
LSCC	CHRM3-AS1 →	-1.041	-0.176	<.001	<.001	3	3
HNSC	MEFV →	+0.661	+0.184	.003	.001	3	3
HNSC	LONRF1 →	-0.674	-0.200	.003	.004	3	3
BRCA	NPM2 →	-0.598	-0.153	<.001	.001	3	3
BRCA	PCYT1A →	-0.334	-0.188	.001	<.001	3	3

Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1904292 vs RARB — LUAD

Explore this scatter interactively →